Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
90.14
+1.21 (1.36%)
At close: Dec 20, 2024, 4:00 PM
90.00
-0.14 (-0.16%)
After-hours: Dec 20, 2024, 4:55 PM EST
Blueprint Medicines Market Cap
Blueprint Medicines has a market cap or net worth of $5.73 billion as of December 20, 2024. Its market cap has increased by 27.67% in one year.
Market Cap
5.73B
Enterprise Value
5.58B
1-Year Change
27.67%
Ranking
Category
Stock Price
$90.14
Market Cap Chart
Since April 30, 2015, Blueprint Medicines's market cap has increased from $469.40M to $5.73B, an increase of 1,119.90%. That is a compound annual growth rate of 29.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 5.73B | 2.12% |
| Dec 29, 2023 | 5.61B | 113.92% |
| Dec 30, 2022 | 2.62B | -58.41% |
| Dec 31, 2021 | 6.30B | 0.83% |
| Dec 31, 2020 | 6.25B | 58.57% |
| Dec 31, 2019 | 3.94B | 66.35% |
| Dec 31, 2018 | 2.37B | -19.85% |
| Dec 29, 2017 | 2.96B | 285.69% |
| Dec 30, 2016 | 766.50M | 7.38% |
| Dec 31, 2015 | 713.80M | 52.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvalent | 6.09B |
| Halozyme Therapeutics | 6.04B |
| Elanco Animal Health | 5.95B |
| Cytokinetics | 5.77B |
| Merit Medical Systems | 5.72B |
| Ionis Pharmaceuticals | 5.67B |
| Inspire Medical Systems | 5.65B |
| Stevanato Group | 5.65B |